Bio-Rad Laboratories Class A
219 hedge funds and large institutions have $2.53B invested in Bio-Rad Laboratories Class A in 2015 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 90 increasing their positions, 67 reducing their positions, and 26 closing their positions.
34% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 67
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
19% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 26
1% more funds holding
Funds holding: 216 → 219 (+3)
0.25% less ownership
Funds ownership: 79.14% → 78.89% (-0.25%)
12% less capital invested
Capital invested by funds: $2.87B → $2.53B (-$337M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SHCM
Sachem Head Capital Management
New York
|
+$34.7M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$30.9M |
| 3 |
Millennium Management
New York
|
+$24.6M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$14.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Americafirst Capital Management
Roseville,
California
|
-$619M |
| 2 |
LCS
Levin Capital Strategies
New York
|
-$53.3M |
| 3 |
RA
Royce & Associates
New York
|
-$19.2M |
| 4 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$17.7M |
| 5 |
ICM
Intrepid Capital Management
Jacksonville Beach,
Florida
|
-$14.1M |
BIO Hedge Fund Activity: Q1 2015 in Review
219 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q1 2015, worth a combined $2.53B — down 12% from $2.87B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new BIO positions and 26 closed out — a net gain of 5 holders — while 90 added to existing stakes and 67 trimmed.
The largest buyer was Sachem Head Capital Management, opening a new position worth an estimated $34.7M. The largest seller was Americafirst Capital Management, exiting entirely with an estimated $619M sold.
- 219 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q1 2015, up from 216 in Q4 2014.
- Funds reported $2.53B of Bio-Rad Laboratories Class A stock for Q1 2015, down 12% quarter-over-quarter.
- 31 funds opened new Bio-Rad Laboratories Class A positions in Q1 2015 and 26 closed out, a net change of +5 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q1 2015 was Sachem Head Capital Management, an estimated $34.7M added.
- The largest Bio-Rad Laboratories Class A seller in Q1 2015 was Americafirst Capital Management, an estimated $619M sold.
Based on aggregated 13F filings for Q1 2015.